Skip to main content

Table 3 Demographic, anthropometric, and clinical variables stratified by signs of self-harm or suicidal ideations, unadjusted data

From: Anxiety and depression symptoms in adolescents and young adults with juvenile idiopathic arthritis: results of an outpatient screening

Variable

Conspicuous screening result

(score of PHQ-9 item 9 ≥ 1)

(n = 125)

Inconspicuous screening result

(score of PHQ-9 item 9 = 0)

(n = 901)

p-value

Sociodemographic / anthropometric data

   

Age, years, mean (SD)

Female, no. (%)

Normal weight, no. (%)

Overweight, no. (%)

15.9 (2.1)

106 (84.8)

69 (58.5)

32 (27.1)

15.3 (2.2)

607 (67.4)

580 (68.6)

161 (19.1)

0.005

< 0.0001

0.027

0.040

JIA specific data

   

Disease duration, years, mean (SD)

Age at disease onset, years, mean (SD)

8.3 (5.1)

7.7 (5.0)

7.1 (4.9)

8.3 (4.7)

0.026

0.208

JIA category, no. (%)

   

RF-positive polyarthritis

RF-negative polyarthritis

Systemic JIA

Persistent oligoarthritis

Extended oligoarthritis

Psoriatic arthritis

Enthesitis-related arthritis

8 (6.3)

32 (25.4)

1 (0.8)

34 (27.0)

27 (21.4)

8 (6.3)

11 (8.7)

34 (3.8)

203 (22.5)

32 (3.6)

245 (27.2)

140 (15.5)

70 (7.8)

137 (15.2)

0.170

0.468

0.100

0.967

0.092

0.575

0.053

cJADAS-10, 0–30, mean (SD)

PGA score, NRS 0–10, mean (SD)

No. of joints with active disease, mean (SD)

5.3 (4.7)

1.5 (2.1)

0.69 (2.4)

4.5 (4.7)

1.4 (1.9)

0.92 (2.6)

0.020

0.683

0.036

Drug therapy (past 12 months)

   

Systemic GCs, no. (%)

Any conventional synthetic DMARD, no. (%)

Any biologic DMARD, no. (%)

14 (11.8)

56 (45.5)

46 (37.1)

68 (8.2)

356 (40.6)

347 (39.3)

0.196

0.298

0.638

Patient-reported data

   

C-HAQ total score, mean (SD)

Well-being, NRS 0–10, mean (SD)

Pain intensity, NRS 0–10, mean (SD)

Fatigue, NRS 0–10, mean (SD)

Coping, NRS 0–10, mean (SD)

0.38 (0.6)

3.3 (2.6)

3.0 (2.8)

4.1 (3.5)

2.5 (2.5)

0.22 (0.4)

2.3 (2.4)

2.3 (2.7)

1.9 (2.7)

1.5 (2.2)

0.004

< 0.0001

0.006

< 0.0001

< 0.0001

  1. JIA, juvenile idiopathic arthritis; RF, rheumatoid factor; cJADAS-10, 10-joint clinical Juvenile Arthritis Disease Activity Score; PGA, physician’s global assessment; C-HAQ, Childhood Health Assessment Questionnaire; GC, glucocorticoid; DMARD, disease-modifying antirheumatic drug; NRS, Numerical Rating Scale; PHQ-9, Patient Health Questionnaire-9. The frequency of possible signs of suicidal or self-harm thoughts are based on PHQ-9 item 9: ‘Thoughts that you would be better off dead, or thoughts of hurting yourself in some way’ with response categories ranging from ‘never’ (score = 0), ‘on several days’ (score = 1), ‘more than half the days’ (score = 2) and ‘almost every day’ (score = 3). The association of sociodemographic and clinical parameters with signs of suicidal or self-harm thoughts was investigated using logistic regression analysis.
Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us